BIAF ▲ +18.1% - bioAffinity Technologies, Inc. $BIAF - bioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic bioAffinity Technologies rose 18.1% today following the company's announcement that it secured a Hong Kong patent for its CyPath® lung cancer diagnostic tool. The patent grant expands the company's intellectual property protection for its noninvasive lung cancer detection technology into a major Asian market. 17-SEP-2026 08:03 AM ET